(Q46961027)

English

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.

scientific article published on 8 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

George K Philips

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Ben L Sanford

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Dean Bajorin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Eric J Small

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cancer and Leukaemia Group B

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

8 October 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

BJU International

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

101

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

20-25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

The systemic treatment of advanced and metastatic bladder cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Overview of bladder cancer trials in the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2007.07226.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2007.07226.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17922873%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46961027&oldid=1584468150"